Skip to main content
. 2018 May 3;45(10):1781–1794. doi: 10.1007/s00259-018-4029-9

Fig. 14.

Fig. 14

An impressive case of treatment response after only one cycle of 225Ac-PSMA 617, the radiopharmaceutical of the year at EANM 2017. Data on therapeutic efficacy [48]